Tarsus Pharmaceuticals, Inc.
TARS
23 insider filings · Latest: Mar 17, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | Mar 19 11:04 PM | Dianne C. WhitfieldChief Human Resources Officer | Sale | 4,174 | $67.00 | $279.7K | 35,028(D) | View → |
| Mar 18, 2026 | Mar 19 11:04 PM | Dianne C. WhitfieldChief Human Resources Officer | Sale | 4,071 | $68.71 | $279.7K | 39,202(D) | View → |
| Mar 17, 2026 | Mar 19 11:04 PM | Dianne C. WhitfieldChief Human Resources Officer | Sale | 4,029 | $69.42 | $279.7K | 43,273(D) | View → |
| Mar 19, 2026 | Mar 19 11:04 PM | Bryan WahlGeneral Counsel | Sale | 4,231 | $67.00 | $283.5K | 63,959(D) | View → |
| Mar 18, 2026 | Mar 19 11:04 PM | Bryan WahlGeneral Counsel | Sale | 4,125 | $68.71 | $283.4K | 68,190(D) | View → |
| Mar 17, 2026 | Mar 19 11:04 PM | Bryan WahlGeneral Counsel | Sale | 4,084 | $69.42 | $283.5K | 72,315(D) | View → |
| Mar 19, 2026 | Mar 19 11:04 PM | Seshadri NeervannanChief Operating Officer | Sale | 4,589 | $67.00 | $307.5K | 85,780(D) | View → |
| Mar 18, 2026 | Mar 19 11:04 PM | Seshadri NeervannanChief Operating Officer | Sale | 3,610 | $68.71 | $248.0K | 90,369(D) | View → |
| Mar 17, 2026 | Mar 19 11:04 PM | Seshadri NeervannanChief Operating Officer | Sale | 3,125 | $69.42 | $216.9K | 93,979(D) | View → |
| Mar 19, 2026 | Mar 19 11:04 PM | Aziz MottiwalaChief Commercial Officer | Sale | 4,440 | $67.00 | $297.5K | 61,480(D) | View → |
| Mar 18, 2026 | Mar 19 11:04 PM | Aziz MottiwalaChief Commercial Officer | Sale | 4,330 | $68.71 | $297.5K | 65,920(D) | View → |
| Mar 17, 2026 | Mar 19 11:04 PM | Aziz MottiwalaChief Commercial Officer | Sale | 4,286 | $69.42 | $297.5K | 70,250(D) | View → |
| Mar 19, 2026 | Mar 19 11:04 PM | Elizabeth Yeu LinChief Medical Officer | Sale | 390 | $67.00 | $26.1K | 23,308(D) | View → |
| Mar 18, 2026 | Mar 19 11:04 PM | Elizabeth Yeu LinChief Medical Officer | Sale | 379 | $68.71 | $26.0K | 23,698(D) | View → |
| Mar 17, 2026 | Mar 19 11:04 PM | Elizabeth Yeu LinChief Medical Officer | Sale | 375 | $69.42 | $26.0K | 24,077(D) | View → |
| Mar 19, 2026 | Mar 19 11:03 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Sale | 2,186 | $67.00 | $146.5K | 43,316(D) | View → |
| Mar 18, 2026 | Mar 19 11:03 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Sale | 2,133 | $68.71 | $146.6K | 45,502(D) | View → |
| Mar 17, 2026 | Mar 19 11:03 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Sale | 2,111 | $69.42 | $146.5K | 47,635(D) | View → |
| Mar 19, 2026 | Mar 19 11:03 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Sale | 11,964 | $67.00 | $801.6K | 33,421(D) | View → |
| Mar 18, 2026 | Mar 19 11:03 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Sale | 11,667 | $68.71 | $801.6K | 45,385(D) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Mar 17 8:40 PM | Dianne C. WhitfieldChief Human Resources Officer | Option Exercise | 23,909 | — | 15,067(D) | View → |
| Mar 15, 2026 | Mar 17 8:38 PM | Bryan WahlGeneral Counsel | Option Exercise | 24,236 | — | 15,067(D) | View → |
| Mar 15, 2026 | Mar 17 8:35 PM | Seshadri NeervannanChief Operating Officer | Option Exercise | 26,287 | — | 15,067(D) | View → |
| Mar 15, 2026 | Mar 17 8:32 PM | Aziz MottiwalaChief Commercial Officer | Option Exercise | 26,482 | — | 16,574(D) | View → |
| Mar 15, 2026 | Mar 17 8:27 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Option Exercise | 13,042 | — | 15,067(D) | View → |
| Mar 15, 2026 | Mar 17 8:24 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Option Exercise | 66,274 | — | 44,634(D) | View → |
| Mar 15, 2026 | Mar 17 8:20 PM | Elizabeth Yeu LinChief Medical Officer | Option Exercise | 2,511 | — | 7,534(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Bryan WahlGeneral Counsel | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Jeffrey S FarrowChief Financial Officer and Chief Strategy Officer | Grant/Award | 50,030 | $74.90 | 19,306(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Aziz MottiwalaChief Commercial Officer | Grant/Award | 50,030 | $74.90 | 19,306(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Seshadri NeervannanChief Operating Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Dianne C. WhitfieldChief Human Resources Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Elizabeth Yeu LinChief Medical Officer | Grant/Award | 44,471 | $74.90 | 17,161(D) | View → |
| Mar 5, 2026 | Mar 9 8:06 PM | Bobak R. AzamianDirector, President/CEO and Board Chair | Grant/Award | 157,499 | $74.90 | 60,776(D) | View → |